Fintel reports that on May 27, 2026, UBS upgraded their outlook for BioNTech SE - Depositary Receipt (NasdaqGS:BNTX) from Neutral to Buy.
Analyst Price Forecast Suggests 42.47% Upside
As of May 14, 2026, the average one-year price target for BioNTech SE - Depositary Receipt is $131.43/share. The forecasts range from a low of $82.93 to a high of $190.05. The average price target represents an increase of 42.47% from its latest reported closing price of $92.25 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for BioNTech SE - Depositary Receipt is 4,403MM, an increase of 56.96%. The projected annual non-GAAP EPS is 2.71.
What is the Fund Sentiment?
There are 278 funds or institutions reporting positions in BioNTech SE - Depositary Receipt. This is an decrease of 100 owner(s) or 26.46% in the last quarter. Average portfolio weight of all funds dedicated to BNTX is 0.15%, an increase of 40.89%. Total shares owned by institutions decreased in the last three months by 12.96% to 47,471K shares. 
The put/call ratio of BNTX is 1.31, indicating a bearish outlook.
What are Other Shareholders Doing?
T. Rowe Price Investment Management holds 5,856K shares. In its prior filing, the firm reported owning 4,485K shares , representing an increase of 23.42%. The firm increased its portfolio allocation in BNTX by 33.00% over the last quarter.
Primecap Management holds 3,794K shares. In its prior filing, the firm reported owning 3,800K shares , representing a decrease of 0.17%. The firm decreased its portfolio allocation in BNTX by 3.05% over the last quarter.
Flossbach Von Storch holds 3,680K shares. In its prior filing, the firm reported owning 4,196K shares , representing a decrease of 14.01%. The firm decreased its portfolio allocation in BNTX by 3.62% over the last quarter.
Dodge & Cox holds 3,677K shares. In its prior filing, the firm reported owning 3,614K shares , representing an increase of 1.69%. The firm decreased its portfolio allocation in BNTX by 3.32% over the last quarter.
Bnp Paribas Arbitrage holds 1,652K shares. In its prior filing, the firm reported owning 1,578K shares , representing an increase of 4.46%. The firm increased its portfolio allocation in BNTX by 4.79% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
